Melatonin as a potential inhibitory agent in head and neck cancer

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Melatonin, secreted by the pineal gland, regulates sleep and circadian rhythms.
• Melatonin exhibits oncostatic properties, particularly studied in hormone-dependent tumors.
• Head and neck cancers are a significant area of research for melatonin's effects.

Purpose of the Study:

• To review recent advances in understanding melatonin's role in head and neck cancer development.
• To highlight molecular mechanisms underlying melatonin's influence on these cancers.
• To provide a basis for further research and clinical applications of melatonin in head and neck oncology.

Main Methods:

• Review of experimental and clinical observations.
• Analysis of molecular mechanisms involved in cancer progression.
• Synthesis of existing research on melatonin and head and neck cancers.

Main Results:

• Melatonin influences multiple cancer development mechanisms, including proliferation, apoptosis, and angiogenesis.
• Extracellular matrix remodeling via matrix metalloproteinases is affected by melatonin.
• Genetic polymorphism interactions with melatonin's effects are considered.

Conclusions:

• Melatonin demonstrates significant potential in controlling head and neck cancer development.
• Understanding melatonin's molecular actions is crucial for therapeutic strategies.
• Further basic and clinical research is warranted to leverage melatonin for head and neck cancer management.